About us

Our five values -Ownership, Integrity, Leadership, Sustainability and Entrepreneurship- guide our patient-oriented corporate culture. We aspire to embody these values in everything we do.

Who we are

We are the largest privately owned and independent plasma fractionator in the world. Our medicines are high-quality human proteins sourced from human plasma and human cell lines.

Diseases & therapies

We develop and manufacture medicines for patients in three therapeutic areas: haematology, immunotherapy and critical care.

Research & development

We carry out pre-clinical and clinical research to develop new products and ensure that they are safe to use. In 2018, we invested €87 million in our research and development work.

Our locations

We are located in 31 countries and our medicines help people in 115 countries around the world. We have seven R&D and six manufacturing sites in Europe and North America.